Sales Enablement for Biotech isn't the same as Sales Enablement for any other vertical. Your buyers are different. Your proof points are different. Your sales cycle is different. Cactus Marketing has worked with 15+ Life science clients served— so we come pre-loaded with the playbooks that work in your market, not ones we'll figure out on your dime.
Life sciences companies, drug discovery platforms, and biotechnology innovators. For Biotech companies, effective Sales Enablement means directly addressing your biggest marketing challenges: Scientific credibility and Investor vs. commercial messaging. That's where most generic agencies fail — they bring the same approach regardless of vertical. We don't.
Scientific credibility
Our Sales Enablement approach directly addresses this — not with a generic playbook, but with Biotech-specific tactics that your buyers actually respond to.
Investor vs. commercial messaging
Our Sales Enablement approach directly addresses this — not with a generic playbook, but with Biotech-specific tactics that your buyers actually respond to.
Long development timelines
Our Sales Enablement approach directly addresses this — not with a generic playbook, but with Biotech-specific tactics that your buyers actually respond to.
Regulatory milestones as marketing triggers
Our Sales Enablement approach directly addresses this — not with a generic playbook, but with Biotech-specific tactics that your buyers actually respond to.
Every deliverable calibrated for Biotech buyer personas and sales cycles.
→ 15+ Life science clients served — we know your market, not just marketing in general
→ Embedded, not external — we work inside your team with access to your CEO, sales data, and customer insights
→ AI-native tools — we deploy the best AI tools to give you 10x output at the same cost
→ Full-stack execution — strategy through pipeline, not just strategy decks
→ 60+ startups, 12 exits, $7B+ in client valuations — proven pattern recognition that works
We've worked with Biotech companies at every stage of the journey — from pre-revenue validation through Series B scale and post-IPO. Our team understands your buyers, your competitive dynamics, and the marketing levers that actually drive results in Biotech. We don't figure it out at your expense.
Book a free 30-minute call. We'll review your current marketing, share specific Sales Enablement strategies that work for Biotech companies, and give you a concrete roadmap.
No generalist advice. No pitch deck. Just a real conversation from people who know your market.
Book a free strategy call →